McDermott Will & Emery has advised NORD Holding on the deal. NORD Holding executed the sale of their majority stake in the OHRWERK Group to Demant...
Demant’s Acquisition of Majority Stake in the OHRWERK Group
NORD Holding’s Acquisition of HKS Health Solutions GmbH
McDermott Will & Emery advised NORD Holding on the transaction. NORD Holding executed the acquisition of HKS health solutions GmbH (HKS). The acquisition of HKS is...
SubjectWell’s Acquisition of Trials24
McDermott Will & Emery represented SubjectWell in the transaction. SubjectWell, a Texas-based provider of the most accurate, diverse, predictable, and patient-centric patient recruitment platform and portfolio...
Great Point Partners’ Acquisition of Lyocontract
McDermott Will & Emery has advised Great Point Partners on the transaction. Great Point Partners (GPP) announced the acquisition of German-based drug product contract development and...
Lifespin GmbH’s Partnership with Acibadem University and Acibadem Healthcare Group
McDermott Will & Emery represented lifespin GmbH on the transaction. German lifespin GmbH, a pioneer in health status detection software, announced it has formed a partnership...
NORD Holding’s Acquisition of a Stake in ABJ alive GmbH
McDermott Will & Emery has advised NORD Holding on the transaction. NORD Holding announced the acquisition of a stake in ABJ alive GmbH (ABJ) as part...
Elos Medtech’s Acquisition of Klingel Medical Group
Renzenbrink & Partner advised IK Partners on the deal while McDermott Will & Emery and Lenz & Staehelin represented Elos Medtech. IK Partners announced the sale...
Myonex’s Acquisition of Hubertus’ Clinical Trial Business Unit
McDermott Will & Emery and Greenfort advised Myonex on the deal. Myonex Inc, a leading global provider of clinical trial supply solutions, executed its acquisition of...
AmerisourceBergen’s $1,3 Billion Acquisition of PharmaLex
Noerr advised AUCTUS, while Freshfields Bruckhaus Deringer advised AmerisourceBergen Corporation. McDermott Will & Emery, Buntscheck and Emnay advised Auctus Capital Partners/Pharmalex. AmerisourceBergen Corporation (NYSE: ABC) signed a...
Vivitide’s Business Combination With Biosynth Carbosynth
McDermott Will & Emery represented Ampersand Capital Partners in the transaction. Ampersand Capital Partners, a healthcare-focused private equity fund, and KKR, a leading global investment firm, finalized...
X1F’s Acquisition of ADWEKO Consulting
GÖRG Partnerschaft von Rechtsanwälten mbB has advised X1F Group, while McDermott Will & Emery has advised the shareholders and CEO of ADWEKO on the deal. X1F...
Neuroloop’s Neurostimulator Collaboration with Merck
Orrick Herrington & Sutcliffe advised neuroloop GmbH on the deal, while McDermott Will & Emery advised Merck KGaA. Neuroloop GmbH, part of B. Braun Group, announced a...